According to research reviewed by Gram, babies born with myelomeningocele in Sub-Saharan Africa often have their spinal opening closed after the recommended 48 to 72 hour window, with median surgery ages of 7 to 11 days in studies from Nigeria, Zambia, and Ethiopia. Access depends on prevention, early diagnosis, and neonatal surgical capacity as much as on the operation itself.
According to research reviewed by Gram, babies born with myelomeningocele, a serious spinal birth defect, often do not get surgery within the recommended first few days of life across Sub-Saharan Africa. This scoping review, published in 2026, combined 28 sources, including 21 primary studies, to map what stands in the way of care. The authors found that distance from hospitals, cost, weak health systems, cultural beliefs, and missed follow-up all play a role. Surgery was often delayed until 7 to 11 days of age in studies from Nigeria, Zambia, and Ethiopia. The researchers also found that folic acid added to food, a proven way to prevent these defects, is required in only some countries. Angola and most Portuguese-speaking African countries have no such rule, and very little local research exists from those nations.
Key Statistics
A 2026 scoping review of 28 sources, including 21 primary studies, found that babies with myelomeningocele in several Sub-Saharan African series had median surgery ages of 7 to 11 days, beyond the recommended 48 to 72 hour window.
A 2026 review reported that South Africa reduced neural tube defect prevalence by more than 30% after adopting mandatory folic acid food fortification in 2003.
A 2026 review of African myelomeningocele studies reported hospital mortality between 5% and 15% and postoperative infection rates between 12% and 30%.
The Quick Take
- What they studied: Researchers wanted to find out what keeps babies with myelomeningocele, a spinal birth defect, from getting timely surgery in Sub-Saharan Africa, with a special focus on Angola.
- Who participated: The review did not enroll patients. It gathered 28 published and unpublished sources, including 21 original studies, from across Sub-Saharan Africa. The authors searched ten databases and reports written in English, Portuguese, French, and Spanish.
- Key finding: Surgery to close the spinal opening often happened after the recommended 48 to 72 hour window. In several studies, the median age at surgery was 7 to 11 days, and hospital deaths ranged from 5% to 15%. Postoperative infections affected 12% to 30% of patients.
- What it means for you: Early diagnosis, prompt neonatal surgery, folic acid in food, and long-term follow-up all appear to shape how well these babies do. If you are planning a pregnancy, taking folic acid before and during early pregnancy is a well-established way to lower the risk of neural tube defects. Talk with a healthcare provider about your own situation.
The Research Details
This study is a scoping review, a type of literature review designed to map out what is known about a topic and where the gaps are. The authors followed a recognized international method from the Joanna Briggs Institute and reported their process using the PRISMA-ScR guideline, which sets standards for transparent reporting.
Two reviewers worked separately to decide which studies to include and to pull out key information from them. Their level of agreement was high, with a Cohen’s kappa score of 0.82, which suggests they judged the studies in a consistent way. The search covered research published between 1990 and mid-2026 in ten databases, along with gray literature such as government reports and conference materials.
Because the review pulled together many different types of sources, it looked at the problem from several angles, including access to prevention, diagnosis, surgery, and follow-up care. This broad view helps explain why the authors describe the issue as a system-wide problem rather than one that only happens in the operating room.
A scoping review is a good tool when a topic is complex and spread across many countries, languages, and types of evidence. Myelomeningocele care involves prevention, hospital services, and years of follow-up, so no single clinical trial could capture all of it. Searching in four languages was especially important because much African health research is published outside major English-language journals.
The review followed an established, transparent method and was published in a peer-reviewed neurosurgery journal. Its strong agreement between reviewers adds confidence. However, scoping reviews do not measure the size of effects or rank treatments, and the included studies vary widely in design, size, and quality. Many sources came from only a few countries, so the findings may not represent the whole continent.
What the Results Show
The review identified seven areas that affect whether children with myelomeningocele can get care: geography, cost, health system strength, sociocultural factors, timing, follow-up, and primary prevention. Across these areas, the authors concluded that the outcome of surgery depends heavily on what happens before and after the operation.
Timing was a major concern. Closing the spinal opening is recommended within 48 to 72 hours after birth, but in series from Nigeria, Zambia, and Ethiopia, the median age at surgery was 7 to 11 days. Long distances to specialized centers, limited neonatal surgical teams, and shortages of referral pathways were all linked to these delays.
Prevention also came up repeatedly. South Africa reported a drop of more than 30% in neural tube defect rates after it made folic acid fortification of food mandatory in 2003. In contrast, Angola and most Portuguese-speaking African countries still lack such policies, and the review found almost no local data from those countries.
Postoperative complications were common in the studies reviewed. Hospital mortality ranged from 5% to 15%, and postoperative infection rates ranged from 12% to 30%. These figures highlight how important infection control, skilled surgical care, and intensive neonatal support are for survival and long-term function.
The review also noted that myelomeningocele is often accompanied by Chiari II malformation and secondary hydrocephalus, a buildup of fluid in the brain, in up to 80% to 90% of cases. This means that many affected children need ongoing monitoring and treatment, not just one surgery. Reports of very high birth rates in Ethiopia and parts of Eastern Africa underline how large the burden is in some regions.
The review’s findings line up with earlier work showing that folic acid fortification substantially lowers neural tube defect rates, as seen in countries that adopted these programs. They also match a broader pattern in global health research: outcomes for complex birth defects are shaped by the health system around the child, including transport, staffing, and follow-up, not just by the surgical skill used in the operating room.
The authors acknowledge several limitations. Scoping reviews do not assess the quality of each study in depth or calculate pooled effect sizes, so the review maps the landscape rather than proving which factor matters most. Data were heavily concentrated in Eastern and Western Africa, leaving very little evidence from Angola and other Portuguese-speaking countries. Many of the included sources are small or local, and their methods vary. The review also reflects what was published and searchable, which may miss unpublished hospital records.
The Bottom Line
Research suggests that three steps may improve outcomes for myelomeningocele: promoting folic acid intake before and during early pregnancy, pushing for mandatory folic acid food fortification where it is missing, and building neonatal referral pathways so that babies reach surgical care within the recommended window. Confidence in the prevention and timing points is relatively high because they are supported by multiple sources and by South Africa’s experience. Confidence in the best specific system design is lower, since the evidence base is limited and uneven.
Pregnant people and those planning a pregnancy, healthcare workers, hospital administrators, and public health officials in Sub-Saharan Africa, especially in Angola and other Portuguese-speaking countries, should pay close attention. Readers living in countries with strong prevention programs and established neonatal surgery services may find the broader lessons useful but will not face the same access barriers described in the review.
Changes in folic acid intake take effect before conception and during early pregnancy, so benefits are linked to pregnancies planned in the coming months. Food fortification policies usually take several years to implement and show measurable effects on birth defect rates. Improvements in surgical timing and follow-up care can happen sooner, but building the staff, transport, and referral networks needed for consistent care often takes years.
Frequently Asked Questions
Why do babies with myelomeningocele in Africa often wait too long for surgery?
A 2026 scoping review found that long travel distances, high costs, limited neonatal surgical teams, weak referral systems, and missed follow-up contribute to delays. In several series from Nigeria, Zambia, and Ethiopia, the median age at surgery was 7 to 11 days, beyond the recommended 48 to 72 hours.
Can folic acid food fortification prevent spina bifida in Africa?
Folic acid fortification is linked to lower rates of neural tube defects. South Africa reported a reduction of more than 30% in neural tube defect prevalence after making fortification mandatory in 2003. Angola and most Portuguese-speaking African countries still lack such policies.
What is the survival rate after surgery for myelomeningocele in Sub-Saharan Africa?
Across the studies reviewed, hospital mortality after surgery for myelomeningocele ranged from 5% to 15%. Postoperative infection rates ranged from 12% to 30%, which shows why infection control and skilled neonatal care are central to better outcomes.
How much folic acid should someone take to lower the risk of neural tube defects?
Healthcare providers commonly recommend that people planning a pregnancy take folic acid daily before conception and during early pregnancy. Dosing can vary by individual risk, so confirm the right amount with a doctor or midwife who knows your health history.
Want to Apply This Research?
- Log a daily folic acid entry, whether from a supplement or a fortified food, and track whether you hit your provider’s recommended amount. For those planning a pregnancy, set a reminder to check in each day for at least one month before conception and through the first trimester.
- Add folic acid-rich or fortified foods such as fortified cereals, leafy greens, beans, and lentils to your weekly meal plan. Pair this with a daily supplement if your provider recommends one, and set a recurring reminder so the habit becomes automatic.
- Keep a long-term record of prenatal appointments, supplement use, and any screening results in the app. If you are a caregiver or health worker tracking newborn care, log surgical dates, follow-up visits, and any complications so that gaps in care can be spotted and addressed early.
This article summarizes a scoping review of published and gray literature. It is for general education and does not replace medical advice. Anyone who is pregnant, planning a pregnancy, or caring for a child with myelomeningocele should consult a qualified healthcare provider about diagnosis, folic acid dosing, surgical timing, and follow-up care.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.